Company Filing History:
Years Active: 2017
Title: Nasser Beniou: Innovator in Pharmaceutical Dosage Forms
Introduction
Nasser Beniou is a notable inventor based in Mulhouse, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of modified release oral dosage forms. His work focuses on improving the delivery and efficacy of medications.
Latest Patents
Nasser Beniou holds a patent for "Dosage forms containing terbutaline sulphate." This innovative patent describes a modified release oral dosage form that comprises an internal phase containing terbutaline sulphate and a pharmaceutically acceptable excipient, which is dispersed in an external phase made up of pharmaceutically acceptable excipients. This formulation aims to enhance the therapeutic effects of terbutaline sulphate, a medication commonly used for respiratory conditions.
Career Highlights
Beniou is currently associated with Jagotec AG, where he continues to advance his research and development efforts in pharmaceutical formulations. His expertise in dosage forms has positioned him as a valuable asset in the industry.
Collaborations
Nasser Beniou collaborates with Alain Nhamias, who is also involved in the pharmaceutical sector. Their partnership reflects a shared commitment to innovation and excellence in drug formulation.
Conclusion
Nasser Beniou's contributions to pharmaceutical science, particularly through his patent on terbutaline sulphate dosage forms, highlight his role as an innovator in the field. His work continues to impact the development of effective medication delivery systems.